Determination of carcinoembryonic antigen and cancer antigen values with the radioimmunoassay method in healthy females dogs

Veterinarni Medicina

Volumn 58, Issue 5, 2013, Pages 277-283

  Ledecky, Valent ^a   Valencakova Agyagosova, A ^a   Lepej, J ^b   Frischova, Z ^b   Hornak, S ^a   Nagy, V ^c  

^a UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

^b Institute of Nuclear and Molecular Medicine (INMM)   (Slovakia)

^c L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

CA 15 3; Canine; CEA; Mammary gland; Tumor markers

Indexed keywords

CANIDAE; CANIS FAMILIARIS;

EID: 84878542055     PISSN: 03758427     EISSN: None     Source Type: Journal    
DOI: 10.17221/6810-VETMED     Document Type: Article

References (24)

1. Akiyama F, Horii R (2009): Therapeutic strategies for breast cancer based on histological type. Breast Cancer 16, 168-172
2. Benjamin SA, Lee AC, Saunders WJ (1999): Classification and behavior of canine mammary epithelial neoplasm based on life-span observations in beagles. Veterinary Pathology 36, 423-436
3. Berruti A, Tampellini M, Torta M, Buniva T, Gorzegno G, Dogliotti L (1994): Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. European Journal of Cancer 30A, 2082-2084
4. Bland KI, Beenken SW, Coopeland EM (2005): The Breast. In: Bruniardi FC, Anderson DK, Billjar TR, Dunn DL, Hunter JG, Pol-lock RE (eds.): Schwartz's Principles of Surgery. 8th McGraw-Hill Companies Inc., New York, NY. 453-496
5. Brodey RS, Goldschmidt MH, Roszel JR (1983): Canine mammary gland neoplasm. Journal of the American Animal Hospital Association 19, 61-90
6. Capik I, Sevcik A, Sevcikova Z (2008): Tumour diseases in dogs. Folia Veterinaria 52, 194-198
7. Ebeling FG, Stieber P, Untuch M, Nagel D, Konecny GE, Schmitt UM, Fateh-Moghadam A, Seidel D (2002): Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. British Journal of Cancer 86, 1217-1222
8. Fiorella G, Patrizia F, Sandro C, Mariotti S, Spila A, Aloe S, D'Alessandro R, Carone MD, Cicchetti A, Ricciotti A, Venturo I, Perri P, Di Filippo F, Cognetti F, Botti C, Roselli M (2001): A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study. Clinical Cancer Research 7, 2357-2362
9. Hahn KA, Richardson RC, Knapp DW (1992): Canine malignant mammary neoplasia: Biological behaviour, diagnosis and treatment alternetives. Journal of American Animal Hospital Association 28, 251-256
10. Kausitz J, Altaner C et al. (eds.) (2003): Tumor Markers. In: Oncology (in Slovak). VEDA-Slovak Academy of Science Publishing, 1st ed. Bratislava. 119-124
11. Kitchel B, Loard A (1997): Diseases of mammary gland. In: Morgan RV (ed.): Handbook of Small Animal Practice. WB Saunders Company, Philadelphia. 615-625
12. Laessig D, Nagel D, Heinemann V, Untch M, Kahlert S, Baufrfeind I, Stieber P (2007): Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients. Anticancer Research 27, 1963-1968
13. Lamerz R, Stieber P, Fatel-Moghadam A (1993): Serum marker combinations in human breast cancer (review). In Vivo 7, 607-614
14. MacEwen EG (1990): Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Review 9, 125-136
15. Misdorp W, Else RW, Hellman E, Lipscomb TP (1999): Histological classification of mammary tumors of the dog and cat. In: World Health Organization: International Histological Classification of Tumors of Domestic Animals. Vol. 7, ser. 2, no. 2, Armed Forces Institute of Pathology, Washington, DC
16. Molina R, Filella X, Alicarte J, Zanon G, Pahisa J, Munoz M, Farrus B, Ballesta AM (2003): Prospective evaluation of CEA and CA 15-3 in patients with locoregional breast cancer. Anticancer Research 23, 1035-1041
17. Molina R, Jo J, Fillela X, Gimenez N (1998): C-erbB-2 oncoprotein, CEA and CA 15-3 in patients with breast cancer: prognostic value. Breast Cancer Research and Treatment 51, 109-119
18. Muthuswamy S, Raste AS (2000): Clinical significance of the CA 15-3 in breast cancer. Indian Journal of Medical Science 54, 442-447
19. O'Hanlon DM, Kerin MJ, Kent PJ, Skehill R, Maher D, Grimes H, Given HF (1995): A prospective evaluation of CA 15-3 in Stage I carcinomas of the breast. Journal of the American College of Surgeon 180, 210-212
20. Owen LN (1980): Classification of Tumors in Domestic Animals. World Health Organization, Geneva
21. Park BW, Oh JW, Kim JH, Park SH, Kim KS, Kim JH, Lee KS (2008): Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes. Annals of Oncology 19, 675-681
22. Safi F, Kohler I, Rottinger E, Beger HE (1991): The value of the tumor markers CA 15-3 in diagnosing and monitoring breast cancer. Cancer 68, 574-582
23. Sikorska H, Shuster J, Gold P (1988): Clinical applications of carcinoembryonic antigen. Cancer Detect Prevent Journal 12, 321-355
24. Winer EP, Morro WM, Kent OC, Harries JR (2001): Malignant tumors of the breast. In: Vincent T Devita Jr, Samuel Hellman, Steven A. Rosenberg: Cancer Principles and Practice of Oncology. 6th ed. Lippincott, Williams & Wilkins, 1698-1699